TY - JOUR
T1 - Standardizing Normal Tissue Contouring for Radiation Therapy Treatment Planning
T2 - An ASTRO Consensus Paper
AU - Wright, Jean L.
AU - Yom, Sue S.
AU - Awan, Musaddiq J.
AU - Dawes, Samantha
AU - Fischer-Valuck, Benjamin
AU - Kudner, Randi
AU - Mailhot Vega, Raymond
AU - Rodrigues, George
N1 - Funding Information:
Sources of support: This paper was funded by the American Society for Radiation Oncology .
Funding Information:
Sources of support: This paper was funded by the American Society for Radiation Oncology.Conflicts of interest: Before initiation of this paper, all members of the Task Force and Review Panel completed disclosure statements. These statements are maintained at ASTRO Headquarters in Arlington, Virginia. ASTRO's Clinical Affairs and Quality Council reviewed these disclosures and determined they do not present a conflict with respect to the Task Force members' work on this consensus paper. Jean Wright: ASTRO (honoraria), International Journal of Radiation Oncology Biology Physics (Associate Editor); Sue S. Yom: ASTRO (honoraria), Genentech, Merck, Bristol-Myers Squibb (research grants), UpToDate, Springer (royalty), American Radium Society (Executive Committee Treasurer, Appropriate Use Criteria Committee Chair), International Journal of Radiation Oncology Biology Physics (Deputy Editor); Raymond Mailhot Vega: Varian (travel expenses) and IBA (travel expenses), George Rodrigues: Demos Publishing Company (royalty), George Rodrigues Medicine Professional Corporation (President, stock).
Publisher Copyright:
© 2018 American Society for Radiation Oncology
PY - 2019/3
Y1 - 2019/3
N2 - Purpose: The comprehensive identification and delineation of organs at risk (OARs) are vital to the quality of radiation therapy treatment planning and the safety of treatment delivery. This guidance aims to improve the consistency of ontouring OARs in external beam radiation therapy treatment planning by providing a single standardized resource for information regarding specific OARs to be contoured for each disease site. The guidance is organized in table format as a quality assurance tool for practices and a training resource for residents and other radiation oncology students (see supplementary materials). Methods and Materials: The Task Force formulated recommendations based on clinical practice and consensus. The draft manuscript was peer reviewed by 16 reviewers, the American Society for Radiation Oncology (ASTRO) legal counsel, and ASTRO's Multidisciplinary Quality Assurance Subcommittee and revised accordingly. The recommendations were posted on the ASTRO website for public comment in June 2018 for a 6-week period. The final document was approved by the ASTRO Board of Directors in August 2018. Results: Standardization improves patient safety, efficiency, and accuracy in radiation oncology treatment. This consensus guidance represents an ASTRO quality initiative to provide recommendations for the standardization of normal tissue contouring that is performed during external beam treatment planning for each anatomic treatment site. Table 1 defines 2 sets of structures for anatomic sites: Those that are recommended in all adult definitive cases and may assist with organ selection for palliative cases, and those that should be considered on a case-by-case basis depending on the specific clinical scenario. Table 2 outlines some of the resources available to define the parameters of general OAR tissue delineation. Conclusions: Using this paper in conjunction with resources that define tissue parameters and published dose constraints will enable practices to develop a consistent approach to normal tissue evaluation and dose documentation.
AB - Purpose: The comprehensive identification and delineation of organs at risk (OARs) are vital to the quality of radiation therapy treatment planning and the safety of treatment delivery. This guidance aims to improve the consistency of ontouring OARs in external beam radiation therapy treatment planning by providing a single standardized resource for information regarding specific OARs to be contoured for each disease site. The guidance is organized in table format as a quality assurance tool for practices and a training resource for residents and other radiation oncology students (see supplementary materials). Methods and Materials: The Task Force formulated recommendations based on clinical practice and consensus. The draft manuscript was peer reviewed by 16 reviewers, the American Society for Radiation Oncology (ASTRO) legal counsel, and ASTRO's Multidisciplinary Quality Assurance Subcommittee and revised accordingly. The recommendations were posted on the ASTRO website for public comment in June 2018 for a 6-week period. The final document was approved by the ASTRO Board of Directors in August 2018. Results: Standardization improves patient safety, efficiency, and accuracy in radiation oncology treatment. This consensus guidance represents an ASTRO quality initiative to provide recommendations for the standardization of normal tissue contouring that is performed during external beam treatment planning for each anatomic treatment site. Table 1 defines 2 sets of structures for anatomic sites: Those that are recommended in all adult definitive cases and may assist with organ selection for palliative cases, and those that should be considered on a case-by-case basis depending on the specific clinical scenario. Table 2 outlines some of the resources available to define the parameters of general OAR tissue delineation. Conclusions: Using this paper in conjunction with resources that define tissue parameters and published dose constraints will enable practices to develop a consistent approach to normal tissue evaluation and dose documentation.
UR - http://www.scopus.com/inward/record.url?scp=85061798865&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061798865&partnerID=8YFLogxK
U2 - 10.1016/j.prro.2018.12.003
DO - 10.1016/j.prro.2018.12.003
M3 - Article
C2 - 30576843
AN - SCOPUS:85061798865
SN - 1879-8500
VL - 9
SP - 65
EP - 72
JO - Practical Radiation Oncology
JF - Practical Radiation Oncology
IS - 2
ER -